Large-dose intravenous methotrexate-induced cutaneous toxicity: can oral magnesium oxide reduce pain?
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12707144.
- Also identified by DOI 10.1213/01.ANE.0000057140.33744.65.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chemotherapy for cancer is associated with pain including cutaneous vasculitis. Magnesium, an N-methyl-D-aspartic acid-receptor antagonist, was used successfully to treat an adolescent with pain caused by cutaneous vasculitis secondary to methotrexate therapy.
Medical subject headings
- Antimetabolites, Antineoplastic
- Drug Eruptions
- Magnesium Oxide
- Methotrexate
- Pain